•
Sep 30, 2022

Soleno Therapeutics Q3 2022 Earnings Report

EPS
-$0.76
Previous year: -$1.5
-49.3%
Cash and Equivalents
$19.8M
Previous year: $28.2M
-29.9%
Free Cash Flow
-$4.66M
Previous year: -$5.41M
-14.0%
Total Assets
$32M
Previous year: $42.6M
-24.9%

Soleno Therapeutics

Soleno Therapeutics